pharma : Latest News, Videos and Photos | Outlook Business
Home » Search
Search Result : "pharma"

The pharma index has hugely underperformed the Sensex in CY17 owing to regulatory overhang and FDA issues 

Nilesh Shetty and Anand Shah on whether pharma stocks can make a comeback

Over the past three years, the NSE Pharma Index has fallen 30% even as the benchmark Nifty rose 18%

Here is a list of stocks that have fallen in the small and mid-cap carnage despite reporting robust numbers

Laurus Lab founder Satyanarayana Chava increases stake as the stock loses steam post its weak show in Q4FY18

Dr Reddy’s promoter GV Prasad buys in the open market amid growing headwind

The worst seems to be behind for Sun Pharma as its Halol plant seems set for clearance and its specialty portfolio tests water in the US

By focusing on its strength in manufacturing lyophilized injectables, Gufic Biosciences has made a strong comeback and wants to aggressively push into the EU market next

When change sets in, companies initially live in denial, and when it catches up, it’s too late

Laurus Labs is crucially poised, as investors look forward to its R&D efforts finally paying off

After emerging as the global leader in the oral care segment, Essel Propack is betting on the non-oral space to sustain its growth momentum

Secret Diary of Ajay Piramal — Part 1

Secret Diary Of Kiran Mazumdar – Part 2

Even as the tax holiday comes to an end, businesses in Pantnagar say better infrastructure will drive future investments and sustain the growth momentum

Business is looking up in Nashik and Aurangabad, but labour issues — rising costs, shortage of skilled workers and unionisation — continue to play spoilsport

Even as the rest of the country grappled with GST, the Naroda cluster wasted no time in getting back on track 

Businesses across the country’s industrial clusters are optimistic about FY19

Neelesh Surana believes some pockets in the market are still cheap and one can expect an overall return of 13-15%

Betting on quality and structural themes is the key to Gautam Sinha Roy’s investing success

Unrelenting commitment towards process and sticking to his conviction have augured well for Invesco’s Taher Badshah

Sailesh Raj Bhan has made optimum use of cyclical downturns to deliver outperformance

Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth

The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market

On Stands Now